v3.23.1

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 3,096	$ 10,155
Prepaid expenses and other current assets	1,930	950
Total current assets	5,026	11,105
Other assets	90	90
Total assets	5,116	11,195
Current liabilities:
Accounts payable	38,392	40,520
Accrued expenses	14,021	14,791
Deferred revenue	883	883
Total current liabilities	53,296	56,194
Non-current liabilities:
Deferred revenue	1,545	1,766
Total liabilities	54,841	57,960
Stockholders’ deficit:
Common stock, $0.001 par value: 225,000,000 shares authorized at March 31, 2023 and December 31, 2022; 119,080,135 shares issued and outstanding at March 31, 2023 and December 31, 2022	119	119
Additional paid-in capital	636,147	634,925
Accumulated deficit	(685,991)	(681,809)
Total stockholders’ deficit	(49,725)	(46,765)
Total liabilities and stockholders’ deficit	$ 5,116	$ 11,195

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

HUMANIGEN, INC 10-Q